Drug Type siRNA, Liposomal Drug |
Synonyms LErafsiRNA, NeoPhectin Raf-1 siRNA, Raf-1 siRNA (NeoPharma) + [2] |
Target |
Action inhibitors |
Mechanism CCND1 inhibitors(Cyclin D1 inhibitors), Raf kinase inhibitors(RAF serine/threonine protein kinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | United States | - |